openPR Logo
Press release

CUSTICS SINGAPORE's Growth Nutrient Patch 'Hautuki' Completes Clinical Study

01-17-2025 06:58 PM CET | Health & Medicine

Press release from: ABNewswire

CUSTICS SINGAPORE's Growth Nutrient Patch 'Hautuki' Completes

Image: https://www.abnewswire.com/upload/2025/01/d0c11fb6ef950d96ffc92b987934691b.jpg

CUSTICS SINGAPORE PTE. LTD. (hereafter referred to as "CUSTICS SINGAPORE [https://hautuki.sg/]") has successfully completed clinical study on its 'Hautuki [https://hautuki.sg/]' growth nutrient patch in collaboration with Bestian Hospital, demonstrating its effectiveness in promoting height growth and confirming its safety. The study was conducted in adherence to Good Clinical Practice (GCP) standards and the approval of the Institutional Review Board (IRB), ensuring its reliability.

From January to November 2024, the study evaluated the effectiveness and safety of Hautuki on 40 children aged 5 to 12 years. The 8-week study revealed that children in the test group using Hautuki experienced an average height increase of 1.77 cm, compared to an average increase of 1.37 cm in the control group, who did not use the patch. This indicates that the test group achieved approximately 30% more growth than the control group.

The clinical study also yielded positive results regarding safety. No adverse effects were reported during the research period, leading to the conclusion that Hautuki is safe for long-term use.

"We are delighted that Hautuki has been scientifically proven to promote height growth and ensure safety," said Kang-il Lee, CEO of CUSTICS SINGAPORE. "This clinical study allows us to strengthen consumer trust in our product, and we remain committed to developing safe and effective solutions that exceed customer expectations."

Based on these clinical findings, Hautuki is expected to gain further attention in the growth products market, offering a reliable choice for consumers. The company plans to continue investing in research and quality improvements to enhance its offerings.

Distributor: Amit Biswas

Distributor Company: Grow With Amit

Contact: cs@hautuki.sg [mailto:cs@hautuki.sg]

Media Contact
Company Name: Grow With Amit
Contact Person: Amit Biswas
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=custics-singapores-growth-nutrient-patch-hautuki-completes-clinical-study]
Country: Singapore
Website: https://www.fiverr.com/grow_withamit



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CUSTICS SINGAPORE's Growth Nutrient Patch 'Hautuki' Completes Clinical Study here

News-ID: 3820907 • Views:

More Releases from ABNewswire

Catheter Related Bloodstream Infections Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Xellia Pharma, Pfizer, Glenmark Pharma, Fresenius Medical Care
Catheter Related Bloodstream Infections Market Positioned for Accelerated Develo …
The Key Catheter Related Bloodstream Infections Companies in the market include - CorMedix, Xellia Pharmaceuticals Ltd., Pfizer, Glenmark Pharmaceuticals Ltd., Fresenius Medical Care, CorMedix, Inc., TauroPhar GmbH, Geistlich Pharma, Citus Pharmaceuticals, AstraZeneca, Merck & Co., Inc., and others. DelveInsight's "Catheter Related Bloodstream Infections Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Catheter Related Bloodstream Infections, historical and forecasted epidemiology as well as the Catheter Related Bloodstream
Excel Properties Uncovers the Factors Behind Dubai's Rising Global Investment Appeal
Excel Properties Uncovers the Factors Behind Dubai's Rising Global Investment Ap …
Some years ago, Dubai was a trading post in the middle of a desert, but nowadays it is one of the most active investment markets in the world. Its strategic location that cuts across the highways that link the East and the West, world-class infrastructure, and pro-business policies have ensured that the city has continued to be attractive to investors in all its sectors. It is enticing entrepreneurs as well
MonetaGuard-SterkKapitaal Emerges as South Africa's Trusted Gateway to Global Trading Opportunities
MonetaGuard-SterkKapitaal Emerges as South Africa's Trusted Gateway to Global Tr …
Image: https://www.abnewswire.com/upload/2025/10/d3a74440485d0e85406a9e59823fcf54.jpg MonetaGuard-SterkKapitaal is redefining trading in South Africa by combining local expertise with global market access. With advanced platforms, over 250 instruments, and a strong focus on client protection, the company offers traders the confidence and convenience they need to succeed. World-Class Market Access MonetaGuard-SterkKapitaal [https://www.monetaguard.com/en/home] provides access to forex, commodities, indices, shares, and more, all on a single platform. South African traders can invest in the world's most influential companies, including
Green Logistics: The Investment Frontier Driving Efficiency and Sustainability
Green Logistics: The Investment Frontier Driving Efficiency and Sustainability
As climate regulations tighten and consumer demand for sustainability increases, logistics is undergoing a quiet but powerful transformation. The traditional model of moving goods, often seen as environmentally costly and operationally rigid, is being replaced with smarter, greener, and more tech-driven systems. This shift is not just reshaping supply chains. It is unlocking fresh investment opportunities for those looking to fund scalable solutions that sit at the intersection of sustainability and

All 5 Releases


More Releases for Hautuki

Hautuki Patch Demonstrates Growth Potential and Safety in Clinical Study
Hautuki Clinically Proven to Support Height Growth and Ensure Safety Custics announced that its height-supporting nutrient patch, Hautuki, has been proven effective and safe through a clinical study conducted at Bestian Hospital over the course of approximately one year. Image: https://www.abnewswire.com/upload/2025/05/75daaface7cea909f35fd494150fea0f.PNG The study was conducted over 11 months, from January to November 2024, and involved 40 children between the ages of 5 and 12. After eight weeks, the group that used the Hautuki patch
Hautuki, A Globally Recognized Innovative Patch Type Nutrition Solution for Chil …
Hautuki, an innovative children's nutrition product manufactured in South Korea, is gaining global recognition. Exported to countries including the United States, Singapore, Hong Kong, Taiwan, Malaysia, Indonesia, China, and the Philippines, Hautuki has established itself as a trusted brand in international markets. CUSTICS, the company behind Hautuki, operates legal entities in South Korea, Singapore, Taiwan, and Hong Kong, strengthening its global presence. Based on its vision to "shine and illuminate," CUSTICS
HAUTUKI Innovates Efficient Vitamin D Delivery for Children through Transdermal …
Recent nutritional surveys conducted both domestically and internationally indicate that more than 80% of children in their growth phase suffer from vitamin D deficiency or insufficiency. Research also shows that children with stunted growth are more prone to vitamin D deficiency compared to their peers. In countries with frequent rainy or overcast days, ensuring adequate vitamin D intake is naturally more challenging. Image: https://www.abnewswire.com/uploads/d2d7d3db97fca5f29490d3971d5e13d5.jpg CUSTICS Inc. (CEO LEE KANG IL), in their
Custics Singapore's HAUTUKI Secures FDA OTC Product Registration and Excels in S …
Custics Singapore announces that HAUTUKI has achieved a significant milestone by securing registration as an OTC Product with the U.S. FDA HAUTUKI, a cutting-edge product developed through technology transferred from Seoul National University, integrates a unique blend of vitamins and nutrients designed to amplify its effectiveness. At the core of HAUTUKI's innovation is a patented peptide ligand from the Department of Biotechnology at Seoul National University. This advanced technology is engineered
CUSTICS Launches Hautuki as an OTC Product in Singapore
CUSTICS SINGAPORE PTE. LTD. has announced that its product, Hautuki, has already completed registration with the U.S. FDA Administration OTC Product. According to a company representative, Hautuki was developed by CUSTICS Co., Ltd. using TDDS technology previously acquired from Seoul National University. This innovative patch integrates vitamins and various nutrients and is specifically designed to support children's growth. Image: https://www.abnewswire.com/uploads/85ea01f2e25cff2bd5d8e29463a3d6d2.png The technology is the "Pore-Permeable Transdermal Peptide Ligand," a patented innovation from the
Hautuki Introduces Safe and Easy Supplements: Skin-Friendly, Hassle-Free Patch S …
Image: https://www.abnewswire.com/uploads/362587e5d32397d9e2bf61339b424669.png Singapore - 9 Aug, 2024 - Custics announced the release of "Hautuki," a height growth supplement using patented peptide technology developed by the Department of Biotechnology at Seoul National University. A Custics official stated that the peptide technology promotes the intracellular delivery of nutrients, enhancing absorption without the need for oral administration. "Hautuki" is registered with the U.S. FDA OTC and has passed skin irritation tests with zero score. The supplement